Your support helps us to tell the story
Support NowThis election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
A brain-zapping headset could be the breakthrough for curing depression at home, a study has found.
The treatment relieves all symptoms of depression in more than half of patients (57.5%) in just 10 weeks, the research suggests.
Experts say the findings could have a “significant impact” on the future treatment of the condition.
The study also showed that the headset, which zaps the brain, was able to improve symptoms in 64.2% of the patients involved in the trial.
No serious side effects associated with using the device were reported in the research published in the Nature Medicine journal.
Allan Young, chairman of mood disorders, director of centre for affective disorders in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, said: “These results are very exciting and are poised to have a significant impact on the future treatment of depression.
“Major depression is undertreated throughout the world, and the current treatment modalities have significant limitations.
“This trial shows that this treatment is both effective and well tolerated, giving patients who are currently struggling to find options that work for them a vital new alternative.”\
The Flow Neuroscience headset uses a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) to stimulate an area of the brain linked with low activity in patients with depression.
The stimulation is delivered through a commercially available device that can be used by patients safely at home.
Patients in the research were on a stable long-term dose of an antidepressant but were still moderately to severely depressed going into the study.
Using the device with the antidepressant led to even better results, with remission rates at 67.1% when combined with an antidepressant, the study in 174 patients with depression found.
Professor Cynthia Fu, the study’s senior author and a professor of affective neuroscience and psychotherapy at King’s IoPPN, said: “The burden of depression is mostly keenly felt by the 280 million people worldwide currently managing symptoms.
“While a combination of antidepressants and therapy generally proves to be effective for many people, medication can have side-effects that some can find disruptive.
“Our study has demonstrated that tDCS is a safe and effective alternative that has the potential to help those in need.”
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
